Drug intelligence / Profile preview

tonghua liyan

Development stage
Unknown
Lead developer
Ding's Internal Medicine Chen Cunren Academic Ideology Research Base
Modality
Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Tonghua Liyan (THLY) is a proprietary traditional Chinese medicine (TCM) formulation available as granules or decoction. It is composed of 11 botanical drugs, 2 animal-derived ingredients, and 1 mineral drug. The formula combines four classic TCM prescriptions—Xuanfu Daizhe Decoction, Banxia Houpu Decoction, Gancao Jiegeng Shegan Decoction, and Zuojin Wan—and is used primarily for the treatment of laryngopharyngeal reflux disease (LPRD), especially in patients with stagnation of phlegm and qi syndrome (SPQS). Mechanistically, its components are reported to reduce throat inflammation by modulating inflammatory cytokines such as TNF-α, IL-6, IL-1β; inhibit gastric acid secretion; regulate esophageal mucosal inflammation; suppress vagal nerve reflexes; and influence pathways including EGFR signaling and arachidonic acid metabolism. Clinical studies suggest that when combined with proton pump inhibitors (PPIs), THLY improves symptoms more effectively than PPIs alone in LPRD patients[1][2][3].

Brand names
Tonghua Liyan granulesTonghua Liyan Decoction
Other names
THLY granulesTHLY decoction
02

Targets

EGFR T790M (Epidermal growth factor receptor T790M mutant)IL-6 (Interleukin 6)TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on tonghua liyan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tonghua liyan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call